WO2003010329A3 - Nucleic acid-associated proteins - Google Patents

Nucleic acid-associated proteins Download PDF

Info

Publication number
WO2003010329A3
WO2003010329A3 PCT/US2002/023756 US0223756W WO03010329A3 WO 2003010329 A3 WO2003010329 A3 WO 2003010329A3 US 0223756 W US0223756 W US 0223756W WO 03010329 A3 WO03010329 A3 WO 03010329A3
Authority
WO
WIPO (PCT)
Prior art keywords
associated proteins
naap
nucleic acid
nucleicacid
polynucleotides
Prior art date
Application number
PCT/US2002/023756
Other languages
French (fr)
Other versions
WO2003010329A2 (en
Inventor
Y Tom Tang
Danniel B Nguyen
Monique G Yao
Bridget A Warren
Jennifer A Griffin
Craig H Ison
Ian J Forsythe
Shanya D Becha
Henry Yue
Brooke M Emerling
Original Assignee
Incyte Genomics Inc
Y Tom Tang
Danniel B Nguyen
Monique G Yao
Bridget A Warren
Jennifer A Griffin
Craig H Ison
Ian J Forsythe
Shanya D Becha
Henry Yue
Brooke M Emerling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Y Tom Tang, Danniel B Nguyen, Monique G Yao, Bridget A Warren, Jennifer A Griffin, Craig H Ison, Ian J Forsythe, Shanya D Becha, Henry Yue, Brooke M Emerling filed Critical Incyte Genomics Inc
Priority to AU2002355292A priority Critical patent/AU2002355292A1/en
Publication of WO2003010329A2 publication Critical patent/WO2003010329A2/en
Publication of WO2003010329A3 publication Critical patent/WO2003010329A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Various embodiments of the invention provide human nucleicacid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.
PCT/US2002/023756 2001-07-26 2002-07-25 Nucleic acid-associated proteins WO2003010329A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002355292A AU2002355292A1 (en) 2001-07-26 2002-07-25 Nucleic acid-associated proteins

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US30818901P 2001-07-26 2001-07-26
US60/308,189 2001-07-26
US30817101P 2001-07-27 2001-07-27
US60/308,171 2001-07-27
US31013901P 2001-08-02 2001-08-02
US60/310,139 2001-08-02
US30997401P 2001-08-03 2001-08-03
US60/309,974 2001-08-03
US31107201P 2001-08-08 2001-08-08
US60/311,072 2001-08-08
US31164201P 2001-08-10 2001-08-10
US31171701P 2001-08-10 2001-08-10
US60/311,717 2001-08-10
US60/311,642 2001-08-10
US32968801P 2001-10-12 2001-10-12
US60/329,688 2001-10-12

Publications (2)

Publication Number Publication Date
WO2003010329A2 WO2003010329A2 (en) 2003-02-06
WO2003010329A3 true WO2003010329A3 (en) 2004-06-10

Family

ID=27575376

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/023756 WO2003010329A2 (en) 2001-07-26 2002-07-25 Nucleic acid-associated proteins

Country Status (2)

Country Link
AU (1) AU2002355292A1 (en)
WO (1) WO2003010329A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
EP1712638B1 (en) * 2003-11-26 2009-06-10 Eisai R&D Management Co., Ltd. Specific marker Lmx1a on dopaminergic neurons
US8082358B2 (en) 2008-09-30 2011-12-20 Microsoft Corporation ISP-friendly rate allocation for P2P applications
EP2737057B1 (en) 2011-07-27 2018-10-24 Kyoto University Novel markers for dopaminergic neuron progenitor cells
US8978079B2 (en) 2012-03-23 2015-03-10 Time Warner Cable Enterprises Llc Apparatus and methods for managing delivery of content in a network with limited bandwidth using pre-caching

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 1 March 2003 (2003-03-01), THE FANTOM CONSORTIUM, XP002975019, Database accession no. Q8BMQ3 *
DATABASE GENBANK [online] 1 October 2000 (2000-10-01), KAWABATA ET AL., XP002975018, Database accession no. Q9NXV0 *

Also Published As

Publication number Publication date
WO2003010329A2 (en) 2003-02-06
AU2002355292A1 (en) 2003-02-17

Similar Documents

Publication Publication Date Title
WO2004087875A3 (en) Nucleic acid-associated proteins
WO2003052075A3 (en) Enzymes
WO2002063005A3 (en) Lipid-associated molecules
WO2003094848A3 (en) Nucleic acid-associated proteins
WO2003029437A3 (en) Secreted proteins
WO2002072794A3 (en) Immunoglobulin superfamily proteins
WO2003042357A3 (en) Enzymes
WO2003004615A3 (en) Secreted proteins
WO2003054219A3 (en) Nucleic acid-associated proteins
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2002026950A3 (en) Transferases
WO2003076586A3 (en) Nucleic acid-associated proteins
WO2003060064A3 (en) Intracellular signaling molecules
WO2002101009A3 (en) Structural and cytoskeleton-associated proteins
WO2003038052A3 (en) Nucleic acid-associated proteins
WO2003010329A3 (en) Nucleic acid-associated proteins
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2001083524A3 (en) Rna metabolism proteins
WO2003063769A3 (en) Vesicle-associated proteins
WO2003031939A3 (en) Protein modification and maintenance molecules
WO2002099115A3 (en) Nucleic acid-associated proteins
WO2003016549A3 (en) Nucleic-acid associated proteins
WO2003006618A3 (en) Nucleic acid-associated proteins
WO2003016506A3 (en) Secreted proteins
WO2003000864A8 (en) Nucleic acid-associated proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE CH CY DE DK FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP